Corresponding Author: Xian Wang

Institute for Cardiovascular Disease, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, No. 5 Haiyuncang, Beijing (China)

Retraction Statement

The article

“Effect of Paclitaxel+Hirudin on the TLR4-MyD88 Signaling Pathway During Inflammatory Activation of Human Coronary Artery Smooth Muscle Cells and Mechanistic Analysis”
[Cell Physiol Biochem 2018;50:1301-1317. DOI: 10.1159/000494588]
by Hongmei Li, Xian Wang and Anlong Xu

has been retracted by the current and former Publisher and the Editor on behalf of the authors.

Following publication of the article, the authors informed the journal that Figure 2, Figure 5 and Figure 6 were previously published in two articles by the authors:

Li Hongmei, Wang Xian. Effect of LPS on inflammatory factor expression in human coronary artery smooth muscle cells cultured in vitro: an exploration of the establishment of a model of restenosis inflammatory cells in the scaffold. Chinese Journal of Evidence-Based Cardiovascular Medicine. 2016;8(3):297-301.

Li Hongmei, Wang Xian. Regulation of the nuclear transcription factor NF-κB p65 and its downstream inflammatory factors during LPS-induced HCASMC inflammatory activation by paclitaxel-hirudin stent-coating complex. China Evidence-Based Cardiovascular Medicine. 2018;10(2):203-206.

The authors requested retraction of this article due to the previous publication of a subset of the results presented.